Kwestionariusz do oceny jakości życia członków rodziny w neurologii: właściwości psychometryczne czeskiej wersji PNDQOL_FM

Abstrakt

KWESTIONARIUSZ DO OCENY JAKOŚCI ŻYCIA CZŁONKÓW RODZINY W NEUROLOGII: WŁAŚCIWOŚCI PSYCHOMETRYCZNE CZESKIEJ WERSJI PNDQOL_FM

Cel pracy. Celem pracy była ocena właściwości psychometrycznych kwestionariusza do oceny jakości życia członków rodziny w neurologii (PNDQoL_FM).

Materiał i metody. Do analizy właściwości psychometrycznych kwestionariusza wykorzystano konfirmacyjną analizę czynnikową wraz z wewnętrzną spójnością skal (rzetelność), retestową rzetelność oraz analizę korelacji. Próba badana obejmowała 157 opiekunów rodzinnych pacjentów z przewlekłą chorobą neurologiczną.

Wyniki. Trafność i rzetelność kwestionariusza PNDQoL_FM uznano za zadowalające. Najlepszą zgodność modelu (TLI=0,973; CFI=0,989; GFI=0,977; SRMR=0,030; RMSEA=0,063;) stwierdzono dla modelu 2, w którym testowano cztery domeny skali funkcjonalnej (emocjonalną, społeczną, duchową), funkcjonowania i ADL. Rzetelność poszczególnych podskal również okazała się zadowalająca (α=0,735-0,923).

Wnioski. Kwestionariusz PNDQoL_FM może być stosowany zarówno w praktyce klinicznej pielęgniarek, jak i w badaniach naukowych. Ocena jakości życia opiekunów pacjentów może być wygodnym wskaźnikiem jakości świadczonej opieki.

The questionnaire for evaluating the quality of life of family members in neurology: Psychometric properties of the Czech version of the PNDQOL_FM.pdf (Angielski)

Bibliografia

1. Oliver DJ, Borasio GD, Caraceni A, et al. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. European Journal of Neurology. 2016; 23:30-38.

2. Golla H, Fink G, Rolke R, et al. New structures in neurology: Palliative care for neurological patients. Neurology International Open. 2017; 01:E117–E126.

3. Iris-Katharina P, Friedemann P. fatigue as a symptom or comorbidity of neurological diseases. Nature Review Neurology. 2017; 13(11):662-675

4. Das P, Naing NN, Wan-Arfah N, et al. Depression and quality of life in patients with neurological disorder in a Malaysian hospital. East Asian Archive of Psychiatry. 2019; 29:66-70.

5. Hellmann-Regen J, Piber D, Hinkelmann K. Depressive syndromes in neurological disorders. European Archives of Psychiatry and Clinical Neuroscience. 2013; 263:S123-S136.

6. Miyasaki JM, Kluger B. Palliative care for Parkinson´s disease: has the time come? Current Neurology Neuroscience Report. 2015; 15: 26.

7. Aarsland D, et al. Mental symptoms in Parkinson´s disease are important contributors to caregiver distress. International Journal of Geriatric Psychology. 1999; 14:866-74.

8. Abendroth M, Lutz BJ, Young ME. Family caregivers‘ decision process to institutionalize persons with Parkinson‘s disease: a grounded theory study. International Journal of Nursing Studies. 2012; 49(4):445-454.

9. Greenwell K, et al. Predictors of the psychosocial impact of being a career of people living with Parkinson’s disease: a systematic review. Parkinsonism and Related Disorders. 2015; 21(1): 1-11.

10. Galvin M, et al. Caregiving in ALS – a mixed methods approach to the study of burden. BMC Palliative Care. 2016; 5: 81.

11. O’Connor EJ, Mc Cabe MP. Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study. Quality of Life Research. 2011; 20: 703-711.

12. Wija P. Poskytování a financování dlouhodobé péče v zemích OECD (III) – poskytování neformální péče a její dopad na zaměstnanost a zdraví. [online] Praha: ÚZIS ČR 2012. derived from: http://www.uzis.cz/system/fi les/33_12.pdf

13. Martínez-Martín P, et al. Caregiver burden in Parkinson’s disease. Movement Disorders. 2007; 22: 924-921.

14. Razali R, et al. Burden of care among caregivers of patients with Parkinson disease: a cross-sectional study. Clinical Neurology and Neurosurgery. 2011; 113: 639-43.

15. The Irish Palliative Care in Parkinson’s Disease Group. Palliative care in People with Parkinson’s disease: Guidelines for professional healthcare workers on the assessment and management of palliative care needs in Parkinson’s disease and related Parkinsonian syndromes. Cork: University College Cork, 2016.

16. Terwee CB, Dekker FW, Wiersinga WM, et al. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Quality of Life Research. 2003; 12: 349-362.

17. Trevittaya P. Concepts of quality of life. Journal of Associated Medical Sciences. 2016; 49(2): 171.

18. WHO. International Classification of Functioning, Disability and Health (ICF). (n.d.). WHO; World Health Organization? Retrieved 7 October 2020, from http://www.who. int/classifi cations/icf/en/.

19. Page TE, Farina N, Brown A, et al. Instruments measuring the dis ease specific quality of life of family carers of people with neurodegenerative dis eases: a systematic review. BMJ Open. 2017; 7(3): e013611.

20. Vickrey BG, Hays RD, Maines ML, et al. Development and preliminary evaluation of a quality of life measure targeted at dementia caregivers. Health and Quality of Life Outcomes. 2009; 7: 56.

21. Doward LC. The development of the Alzheimer’s carers quality of life instrument. Quality of Life Research. 1997; 6(Suppl 7-8): 639

22. Cole CC, Ito D, Chen YJ, et al. Impact of Alzheimer’s disease on caregiver questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden. Health Qual Life Outcomes. 2014; 12: 114.

23. Thomas P, Lal Loue F, Preux PM, et al. Dementia patients caregivers quality of life: the PIXEL study. International Journal of Geriatry Psychiatry. 2006; 21(1): 50-56.

24. Logsdon RG, Gibbons LE, McCurry SM, et al. Quality of life in Alzheimer‘s disease: patient and caregiver reports. Journla of Mental Health Aging. 1999; 5(1): 21-32.

25. Aubeeluck A, Buchanan H. The Huntington’s disease quality of life battery for carers: reliability and validity. Clinal Genetic. 2007; 71(5): 434-445.

26. Aubeeluck A, Dorey J, Squitieri F, et al. Further evidence of reliability and validity of the Huntington’s disease quality of life battery for carers: Italian and French translations. Quality of Life Research. 2013; 22(5): 1093-1098.

27. Benito-Leon J, Rivera-Navarro J, Guerrero AL, et al. The CAREQOL-MS was a useful instrument to measure caregiver quality of life in multiple sclerosis. Journal of Clinical Epidemiology. 2011; 64(6): 675-686.

28. Jenkinson C, Dummett S, Kelly L, et al. The development and validation of a quality of life measure for the carers of people with Parkinson’s disease (the PDQ-Carer). Parkinsonism and Related Disorders. 2012; 18(5): 483-487.

29. Morley D, Dummett S, Kelly L, et al. The PDQ-Carer: development and validation of a summary index score. Parkinsonism and Related Disorders. 2013; 19(4): 448-449.

30. Pillas M, Selai C, Quinn NP, et al. Development and validation of a carers quality-of-life questionnaire for Parkinsonism (PQoL Carers). Quality of Life Research. 2016; 25(1): 81-88.

31. Bužgová R, Kozáková R. Development and psychometric evaluation of a progressive neurological disease quality of life questionnaire (PNDQoL). Current psychology. 2021. Published first online us https://doi.org/10.1007/s12144-021-02183-8.

32. Bužgová R, Kozáková R. Dotazníky pro hodnocení kvality života pacientů s progresivním neurologickým onemocněním a jejich rodinných příslušníků: manual pro uživatele. Ostravská univerzita, 2020.

33. Boateng GO, Beilands T|B, Frongillo EA, et al. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Frontiers in public health. 2018; 6: 1-18.

34. Mundfrom DJ, Shaw DG, Lu Ke T. Minimum sample recommendations for conducting factor analyses. International Journal of Testing. 2005; 5(2): 159-168.

35. Hooper D, Coughlan J, Mullen MR. Structural equation modelling: Guidelines for determining model fit. Electric Journal of Business Research Methods. 2008; 6: 53­-60.

36. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structur Eq Model. 1999; 6: 1-55.

37. Steiner DL, Norman GR. Health Measurement Scales. A Practical Guide to Their Development and Use. New York, Oxford University Press, 2003.

38. Peterson RA. A Meta-analysis of Cronbach’s Coefficient Alpha. Journal of Cons Research. 1994; 21: 381-391.

39. Ware JE, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. Journal of Clinical Epididemiology. 1998; 51: 945-952.

40. Charalambous A, Adamakidou T. Construction and validation of the quality of oncology nursing care scale. BMC Nursing. 2014; 13: 48.

41. Johnson S, et al. Quality of Life Perspectives of People with Amyotrophic Lateral Sclerosis and Their Caregivers. The American Journal of Occupational Therapy. 2017; 71(3): 7103190010p1-7103190010p7.

42. Strand JJ, et al. Top 10 things palliative care clinicians wished everyone knew about palliative care. Mayo Clinical Process. 2013;88(8):859–865.

43. Londral A, Pinto A, Pinto S et al. Quality of life in amyotrophic lateral sclerosis patients and caregivers: impact of assistive communication from early stages. Muscle & Nerve 2015; 52: 933-941.

44. Hussain J, Adams D, Campbell C. End-of-life care in neurodegenerative conditions: outcomes of a specialist palliative neurology service. International Journal of Palliative Nursing. 2013; 19(4): 162-169.

Creative Commons License

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.

Prawa autorskie (c) 2022 Autorzy